Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer-Reference-Cited by-同舟云学术

Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer

Published:2014-05-23 Issue:1 Volume:32 Page:89-96
ISSN:1021-335X
Container-title:Oncology Reports
language:en
Short-container-title:

Author:

KINOSHITA JUN,FUSHIDA SACHIO,TSUKADA TOMOYA,OYAMA KATSUNOBU,WATANABE TOSHIHUMI,SHOJI MASATOSHI,OKAMOTO KOICHI,NAKANUMA SHINICHI,SAKAI SEISHO,MAKINO ISAMU,FURUKAWA HIROYUKI,HAYASHI HIRONORI,NAKAMURA KEISHI,INOKUCHI MASAHUMI,NAKAGAWARA HISATOSHI,MIYASHITA TOMOHARU,TAJIMA HIDEHIRO,TAKAMURA HIROYUKI,NINOMIYA ITASU,FUJIMURA TAKASHI,MASAKAZU YASHIRO,HIRAKAWA KOSEI,OHTA TETSUO

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative strategies for effective paclitaxel delivery: Recent developments and prospects;Journal of Oncology Pharmacy Practice;2024-01-10

2. Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts;International Journal of Nanomedicine;2024-01

3. Advances in the management of peritoneal malignancies;Nature Reviews Clinical Oncology;2022-09-07

4. Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review;Clinical & Experimental Metastasis;2022-06-23

5. Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study;BMC Gastroenterology;2022-06-14